2010 by Oleg Bassovitch
Recently published Letter to the Editor titled “Intermittent hypoxic training: risks versus benefits” (Hinghofer-Szalkay, 2010) suggested inquiring into the long-term risks of Intermittent Hypoxic Training” (IHT), that is also called Therapeutic Hypoxia (TH). The letter points at potential risk of Reactive Oxygen Species (ROS) formation. From the biomedical point of view it is important to separate hazards associated with the use of a device / system and physiological risks and benefits of the therapy itself.
Undoubtfully, a device for human or animal treatments must be meeting essential requirements for medical devices e.g. electrical medical safety and electromagnetic compatibility (IEC 60601-1, 2007).
Devices and systems for hypoxia intervention are called “hypoxicators” and were recently suggested by Australian Therapeutic Goods Administration being mandatory regulated for all applications (TGA, 2008). Hypoxicator falls under the common definition of medical device because of it intended use e.g. “modification of physiological process” (Council Directive 93/42/EEC, 1993).
This letter is a brief review of physiological risks associated with the use of hypoxicators and IHT for human performance enhancement, in both athletic and sedentary populations.
http://www.springerlink.com/content/4632×38184754513/